During the past decade, Cornell Univ Medical College; Hematology-Oncolog conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cornell Univ Medical College; Hematology-Oncolog" #1 collaborator was "Chugai Pharmaceutical" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cornell Univ Medical College; Hematology-Oncolog" are "Hemophilia A" (3 trials), "CML" (1 trials) and "GIST and CML" (1 trials). Many other conditions were trialed in "Cornell Univ Medical College; Hematology-Oncolog" in a lesser frequency.

Most popular intervention types in "Cornell Univ Medical College; Hematology-Oncolog" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Emicizumab" (2 trials), "Bypassing Agents" (1 trials), "FVIII Replacement" (1 trials), "Factor VIII (FVIII)" (1 trials) and "aPCC" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cornell Univ Medical College; Hematology-Oncolog" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Cornell Univ Medical College; Hematology-Oncolog". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Cornell Univ Medical College; Hematology-Oncolog, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cornell Univ Medical College; Hematology-Oncolog, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".